Stock Details
TAK is Takeda Pharmaceutical Company Limited's stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 14.20$. Average daily volumn in 3 months 2.7M. Market cap 43.66B



Stock symbol : TAK. Exchange : NYSE. Currency : USD
Lastest price : 14.06$. Total volume : 3.43M. Market state POSTPOST
Click reload if you want to check the lastest price on market!!!

Takeda Pharmaceutical Company Limited (TAK)
Last Price
14.06$
Change
0.22
Volume
3.43M

Previous Close13.84
Open13.93
Day Range13.93-14.12
Bid14.00 x 3.1k
Ask14.25 x 4k
Volume3.43M
Average Volume2.7M
Market Cap43.66B
Beta0.90
52 Week Range13.05-17.31
Trailing P/E26.04
Foward P/E7.17
Dividend (Yield %)5.71%
Ex-Dividend Date2021-09-29



Financial Details


According to Takeda Pharmaceutical Company Limited's financial reports the company's revenue in 2022 were 3.57T an increase(0%) over the years 2021 revenue that were of 3.2T. In 2022 the company's total earnings were 230.06B while total earnings in 2021 were 376B(-38.83%).


Loading ...



Organization

Takeda Pharmaceutical Company Limited engages in the research, development, manufacturing, marketing, and out-licensing of pharmaceutical products worldwide. It offers pharmaceutical products in the areas of gastroenterology; oncology; neuroscience; and rare diseases, such as rare metabolic and hematology, and heredity angioedema, as well as plasma-derived therapies and vaccines. The company provides its products under the Entyvio, Gattex/Revestive, Alofisel, Natpara, Adynovate/Adynovi, Takhzyro... , Elaprase, Vpriv, Gammagard Liquid/Kiovig, Hyqvia, Cuvitru, Albumin/Flexbumin, Ninlaro, and Alunbrig brands. Takeda Pharmaceutical Company has licensing agreements with Denali Therapeutics and Wave Life Sciences Ltd; collaboration agreements with Neurocrine Biosciences, Inc. and Rani Therapeutics LLC; license and research agreements with The University of Texas MD Anderson Cancer Center, Poseida Therapeutics, Inc., and Arrowhead Pharmaceuticals Inc.; research collaboration agreements with Arrowhead Pharmaceuticals Inc. and Ovid Therapeutics Inc.; and collaboration with Evox Therapeutics Ltd., as well as a licensing agreement with ProThera Biologics Inc. It also has strategic alliances with Egle Therapeutics SAS; Evotec SE; Neurocrine Biosciences, Inc.; Carmine Therapeutics; HemoShear Therapeutics, LLC; KSQ Therapeutics; and Anima Biotech. Takeda Pharmaceutical Company Limited was founded in 1781 and is headquartered in Tokyo, Japan.

Market Cap:
43.66B
Revenue:
3.57T
Total Assets:
13.18T
Total Cash:
849.7B



News about "Takeda Pharmaceutical Company Limited"

caprock-group-inc-has-264000-holdings-in-takeda-pharmaceutical-company-limited-nysetak-image

CAPROCK Group Inc. Has $264,000 Holdings in Takeda Pharmaceutical Company Limited (NYSE:TAK)

Source from : Defense World - 2 days ago

CAPROCK Group Inc. lifted its stake in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK โ€“ Get Rating) by 21.1% in the 1st quarter, according to the company in its most recent 13F filing with ...See details»


veriti-management-llc-makes-new-394000-investment-in-takeda-pharmaceutical-company-limited-nysetak-image

Veriti Management LLC Makes New $394,000 Investment in Takeda Pharmaceutical Company Limited (NYSE:TAK)

Source from : Defense World - 3 days ago

Veriti Management LLC bought a new position in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK โ€“ Get Rating) in the first quarter, HoldingsChannel.com reports. The firm bought 27,504 shares ...See details»


Takeda Pharmaceutical (OTCMKTS:TKPYY) Sets New 12-Month Low at $13.15

Source from : ETF Daily News - 14 days ago

Takeda Pharmaceutical Company Limited (OTCMKTS:TKPYY โ€“ Get Rating) hit a new 52-week low during mid-day trading on Monday . The company traded as low as $13.15 and last traded at $13.17 ...See details»


takeda-leases-future-kendall-square-building-image

Takeda leases future Kendall Square building

Source from : The Business Journals - 5 days ago

Drugmaker Takeda is taking 600,000 square feet at a building under development in Kendall Square, part of an effort to consolidate more of its operations in the neighborhood ...See details»


TAK Takeda Pharmaceutical Company Limited

Source from : Seeking Alpha - 12 days ago

**NM signifies a non meaningful value. A dash signifies the data is not available.See details»


Takeda Pharmaceutical Co Ltd - Stock Quote TKPHF

Source from : Morningstar%2c Inc. - 13 days ago

There is no one analyst in which a Quantitative Star Rating and Fair Value Estimate is attributed to; however, Mr. Lee Davidson, Head of Quantitative Research for Morningstar, Inc., is responsible ...See details»


Takeda Pharmaceutical Company Limited (TKDA.SG)

Source from : Yahoo Finance - 28 days ago

[vii] CAMBRIDGE, Mass. & OSAKA, Japan, May 31, 2022--Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) ("Takeda") today announced that it will present data at two upcoming scientific ...See details»


Takeda Pharmaceutical (NYSE:TAK) Hits New 52-Week Low at $13.15

Source from : ETF Daily News - 14 days ago

Takeda Pharmaceutical Company Limited (NYSE:TAK โ€“ Get Rating) hit a new 52-week low during trading on Monday . The stock traded as low as $13.15 and last traded at $13.17, with a volume of ...See details»


Takeda Pharmaceutical Co. Ltd. ADR

Source from : Wall Street Journal - 13 days ago

Earnings Per Share (TTM) A company's net income for the trailing twelve month period expressed as a dollar amount per fully diluted shares outstanding. Market Capitalization Reflects the total ...See details»


japanese-drug-giant-takeda-will-move-into-16-story-building-planned-for-kendall-square-image

Japanese drug giant Takeda will move into 16-story building planned for Kendall Square

Source from : The Boston Globe on MSN.com - 5 days ago

The company says it wants to create a consolidated campus in Cambridge and is signing a 15-year lease on a planned 600,000 square-foot lab and office space at 585 Third St.See details»


Takeda Presents Latest Research from Oncology Portfolio and Pipeline at ASCO & EHA

Source from : The Globe and Mail - 28 days ago

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK)(โ€œTakedaโ€) today announced that it will present data at two upcoming scientific congresses this spring: the 58 th Annual Meeting of the ...See details»


japans-five-hottest-biotech-companies-in-healthcare-image

Japanโ€™s five hottest biotech companies in healthcare

Source from : the Top 10 - 13 days ago

While historically lacking in foreign investments, Japanโ€™s biotech scene is now thriving with global investors showing increasing interest. Here are five of the hottest Japanese private companies ...See details»


Takeda and Moderna Announce Plans to Transfer Marketing Authorization for Spikevax(TM) COVID-19 Vaccine in Japan to Moderna

Source from : Stockhouse - 28 days ago

any question and answer session and any written or oral material discussed or distributed by Takeda Pharmaceutical Company Limited (โ€œTakeda”) regarding this release. This press ...See details»


Takeda's Dengue Vaccine Candidate Provides Continued Protection Against Dengue Fever Through 4.5 Years in Pivotal Clinical Trial

Source from : Stockhouse - 19 days ago

For the purposes of this notice, โ€œpress release” means this document, any oral presentation, any question and answer session and any written or oral material discussed or ...See details»